AB Science (France) Today
| AB Stock | EUR 1.34 0.01 0.75% |
PerformanceOK
| Odds Of DistressLow
|
AB Science is trading at 1.34 as of the 27th of February 2025, a 0.75% up since the beginning of the trading day. The stock's open price was 1.33. AB Science has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was founded in 2001 and is headquartered in Paris, France. AB SCIENCE operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. The company has 46.86 M outstanding shares. More on AB Science SA
Moving together with AB Science Stock
Moving against AB Science Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AB Science Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AB Science's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AB Science or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
AB Science SA (AB) is traded on Euronext Paris in France and employs 100 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 314.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AB Science's market, we take the total number of its shares issued and multiply it by AB Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AB Science SA classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 46.86 M outstanding shares.
AB Science SA has accumulated about 0 in cash with (17.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check AB Science Probability Of Bankruptcy
Ownership AllocationAB Science SA secures a total of 46.86 Million outstanding shares. AB Science SA shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check AB Science Ownership Details
AB Science SA Risk Profiles
Although AB Science's alpha and beta are two of the key measurements used to evaluate AB Science's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.98 | |||
| Semi Deviation | 4.55 | |||
| Standard Deviation | 11.02 | |||
| Variance | 121.43 |
AB Science Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AB Science without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
AB Science Corporate Management
Elected by the shareholders, the AB Science's board of directors comprises two types of representatives: AB Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AB Science. The board's role is to monitor AB Science's management team and ensure that shareholders' interests are well served. AB Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AB Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Harshad KULKARNI | Head Statistics | Profile | |
| Alain MBA | Chairman, CoFounder | Profile | |
| Yves MD | Head Pharmacovigilance | Profile | |
| Laurent MBA | Chief Officer | Profile | |
| Alexis BERNARD | Head Sales | Profile | |
| Albert DVM | Pres Operations | Profile | |
| Christian FASSOTTE | Global Officer | Profile |
Other Information on Investing in AB Science Stock
AB Science financial ratios help investors to determine whether AB Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AB Science with respect to the benefits of owning AB Science security.